script.reportAU
Sponsor

BeiGene Aus Pty Ltd

8 PBAC submissions on file, active 2021–2025. 88% have been recommended.

Submissions
8
2021 → 2025
Win rate
88 %
7 recommended of 8 bucketable
Drugs
2 · 2 listed
unique molecules submitted
PBS spend captured
$77M
FY-latest govt benefit on owned drugs

Drug portfolio

Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.

Therapy area mix

Haematology 7
Oncology 1

Activity by year

2021 (2) · 2022 (1) · 2023 (2) · 2024 (2) · 2025 (1)

Open on full dashboard →